Janus Henderson Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390M Sell
1,107,159
-1,215,634
-52% -$433M 0.19% 124
2025
Q4
$760M Sell
2,322,793
-321,789
-12% -$102M 0.34% 63
2025
Q3
$746M Sell
2,644,582
-240,353
-8% -$69.7M 0.34% 58
2025
Q2
$805M Buy
2,884,935
+342,446
+13% +$97M 0.39% 49
2025
Q1
$780M Sell
2,542,489
-221,414
-8% -$65.4M 0.43% 42
2024
Q4
$720M Sell
2,763,903
-2,379,427
-46% -$706M 0.37% 53
2024
Q3
$1.66B Buy
5,143,330
+538,545
+12% +$176M 0.85% 15
2024
Q2
$1.44B Buy
4,604,785
+2,223,652
+93% +$653M 0.77% 18
2024
Q1
$677M Buy
2,381,133
+1,377,007
+137% +$403M 0.37% 53
2023
Q4
$289M Buy
1,004,126
+73,147
+8% +$19.9M 0.17% 137
2023
Q3
$250M Sell
930,979
-303,402
-25% -$75.7M 0.16% 145
2023
Q2
$274M Buy
1,234,381
+84,823
+7% +$19.7M 0.17% 140
2023
Q1
$278M Buy
1,149,558
+417,024
+57% +$102M 0.18% 128
2022
Q4
$192M Buy
732,534
+257,862
+54% +$69.1M 0.14% 163
2022
Q3
$107M Buy
474,672
+396,257
+505% +$96.1M 0.04% 346
2022
Q2
$19.1M Sell
78,415
-307,278
-80% -$75.3M 0.01% 574
2022
Q1
$93.3M Sell
385,693
-511,494
-57% -$118M 0.05% 336
2021
Q4
$202M Sell
897,187
-514,432
-36% -$109M 0.08% 232
2021
Q3
$300M Sell
1,411,619
-26,516
-2% -$6.1M 0.13% 180
2021
Q2
$351M Buy
1,438,135
+464,461
+48% +$114M 0.15% 161
2021
Q1
$242M Sell
973,674
-196,611
-17% -$46.9M 0.11% 199
2020
Q4
$269M Buy
1,170,285
+242,881
+26% +$56M 0.13% 175
2020
Q3
$236M Buy
927,404
+297,130
+47% +$73.6M 0.12% 176
2020
Q2
$149M Buy
630,274
+369,694
+142% +$84.3M 0.08% 240
2020
Q1
$52.8M Buy
260,580
+109,254
+72% +$23.9M 0.04% 445
2019
Q4
$36.5M Sell
151,326
-94,740
-39% -$20.9M 0.02% 684
2019
Q3
$47.6M Sell
246,066
-135,402
-35% -$26M 0.03% 589
2019
Q2
$70.3M Sell
381,468
-81,057
-18% -$14.5M 0.04% 487
2019
Q1
$87.9M Buy
462,525
+261,879
+131% +$50M 0.05% 419
2018
Q4
$39.1M Buy
200,646
+4,860
+2% +$948K 0.02% 600
2018
Q3
$40.6M Sell
195,786
-24,562
-11% -$4.84M 0.02% 645
2018
Q2
$40.7M Sell
220,348
-327,940
-60% -$58M 0.02% 611
2018
Q1
$93.5M Sell
548,288
-2,681,509
-83% -$492M 0.06% 385
2017
Q4
$562M Buy
3,229,797
+38,414
+1% +$6.8M 0.34% 69
2017
Q3
$595M Sell
3,191,383
-507,968
-14% -$90M 0.38% 55
2017
Q2
$637M Buy
3,699,351
+3,601,087
+3,665% +$586M 0.43% 41
2017
Q1
$16.1M Sell
98,264
-1,102
-1% -$183K 0.11% 226
2016
Q4
$14.5M Buy
99,366
+10,721
+12% +$1.61M 0.11% 236
2016
Q3
$14.8M Sell
88,645
-2,468
-3% -$417K 0.11% 227
2016
Q2
$13.9M Sell
91,113
-6,968
-7% -$1.08M 0.12% 223
2016
Q1
$14.7M Sell
98,081
-74,220
-43% -$11M 0.12% 203
2015
Q4
$28M Buy
172,301
+75,783
+79% +$11.9M 0.22% 122
2015
Q3
$13.3M Hold
96,518
0.12% 208
2015
Q2
$14.8M Sell
96,518
-3,675
-4% -$589K 0.12% 212
2015
Q1
$16M Sell
100,193
-10,109
-9% -$1.59M 0.12% 211
2014
Q4
$17.6M Sell
110,302
-7,356
-6% -$1.15M 0.13% 203
2014
Q3
$16.5M Sell
117,658
-2,740
-2% -$358K 0.16% 140
2014
Q2
$14.3M Buy
120,398
+7,178
+6% +$831K 0.13% 171
2014
Q1
$14M Buy
113,220
+4,984
+5% +$604K 0.14% 170
2013
Q4
$12.4M Hold
108,236
0.12% 183
2013
Q3
$12.1M Buy
108,236
+3,604
+3% +$391K 0.13% 169
2013
Q2
$10.2M Buy
+104,632
New +$10.9M 0.12% 186

Other funds holding AMGN

Janus Henderson Group's AMGN Position: Q1 2026 in Review

Janus Henderson Group reduced its Amgen (AMGN) stake by 52% in Q1 2026, selling an estimated $433M and leaving 1,107,159 shares worth $390M. The position accounts for 0.19% of the portfolio, ranked #124.

Janus Henderson Group first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.66B in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Janus Henderson Group held 1,107,159 shares of Amgen worth $390M as of Q1 2026.
  • Janus Henderson Group sold 1,215,634 Amgen shares in Q1 2026, an estimated $433M.
  • Amgen made up 0.19% of Janus Henderson Group's portfolio in Q1 2026, its #124 holding.
  • Janus Henderson Group first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's Amgen position peaked at $1.66B in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.